These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Primary bladder neck dysfunction in children and adolescents II: results of treatment with alpha-adrenergic antagonists. Donohoe JM; Combs AJ; Glassberg KI J Urol; 2005 Jan; 173(1):212-6. PubMed ID: 15592078 [TBL] [Abstract][Full Text] [Related]
23. Effects of prazosin in men with symptoms of bladder neck obstruction and a non-hyperplastic prostate. Hedlund H; Andersson KE Scand J Urol Nephrol; 1989; 23(4):251-4. PubMed ID: 2480639 [TBL] [Abstract][Full Text] [Related]
25. Role of alpha adrenergic blocker in the management of posterior urethral valves. Abraham MK; Nasir AR; Sudarsanan B; Puzhankara R; Kedari PM; Unnithan GR; Damisetti KR; Narayanan T Pediatr Surg Int; 2009 Dec; 25(12):1113-5. PubMed ID: 19727771 [TBL] [Abstract][Full Text] [Related]
26. Clinical comparison of selective and non-selective alpha 1A-adrenoceptor antagonists for bladder outlet obstruction associated with benign prostatic hyperplasia: studies on tamsulosin and terazosin in Chinese patients. The Chinese Tamsulosin Study Group. Na YJ; Guo YL; Gu FL J Med; 1998; 29(5-6):289-304. PubMed ID: 10503165 [TBL] [Abstract][Full Text] [Related]
27. [Therapy of benign prostatic hyperplasia with alpha receptor blockers]. Stockamp K Urologe A; 1995 Jan; 34(1):3-8. PubMed ID: 7533449 [TBL] [Abstract][Full Text] [Related]
29. Urodynamic and clinical effects of noninvasive and minimally invasive treatments in elderly men with lower urinary tract symptoms stratified according to the grade of obstruction. Witjes WP; Robertson A; Rosier PF; Neal DE; Debruyne FM; de la Rosette JJ Urology; 1997 Jul; 50(1):55-61. PubMed ID: 9218019 [TBL] [Abstract][Full Text] [Related]
30. An observational urodynamic evaluation of men with lower urinary tract symptoms treated with doxazosin. Gerber GS; Kim JH; Contreras BA; Steinberg GD; Rukstalis DB Urology; 1996 Jun; 47(6):840-4. PubMed ID: 8677574 [TBL] [Abstract][Full Text] [Related]
31. Bladder neck dysfunction: the effect of the alpha-adrenergic blocking agent phentolamine on bladder neck dysfunction and a fluorescent histochemical study of bladder neck smooth muscle. Kaneko S; Minami K; Yachiku S; Kurita T Invest Urol; 1980 Nov; 18(3):212-8. PubMed ID: 6159335 [TBL] [Abstract][Full Text] [Related]
32. [Upper urinary tract urodynamics in vesico-ureteral reflux in children]. Derzhavin VM; Vishnevskiĭ EL; Kazachkov SA; Li AV Urol Nefrol (Mosk); 1982; (2):11-5. PubMed ID: 7080302 [No Abstract] [Full Text] [Related]
33. Increased contractile response to phenylephrine in detrusor of patients with bladder outlet obstruction: effect of the alpha1A and alpha1D-adrenergic receptor antagonist tamsulosin. Bouchelouche K; Andersen L; Alvarez S; Nordling J; Bouchelouche P J Urol; 2005 Feb; 173(2):657-61. PubMed ID: 15643283 [TBL] [Abstract][Full Text] [Related]
34. Unstable bladder activity and the rate of resolution of vesico-ureteric reflux. Taylor CM Contrib Nephrol; 1984; 39():238-46. PubMed ID: 6744874 [No Abstract] [Full Text] [Related]
35. The measurement of lower urinary tract obstruction in infants and children. O'Donnell B; Vella L; Maloney M J Pediatr Surg; 1967 Dec; 2(6):518-22. PubMed ID: 6080295 [No Abstract] [Full Text] [Related]
36. Single-blind, randomized controlled study of the clinical and urodynamic effects of an alpha-blocker (naftopidil) and phytotherapy (eviprostat) in the treatment of benign prostatic hyperplasia. Kaplan SA J Urol; 2005 Sep; 174(3):1011. PubMed ID: 16094031 [No Abstract] [Full Text] [Related]
37. [The unstable detrusor and vesico-ureteral reflux (a group of 20 children)]. Kocvara R; Hanus T; Dvorácek J; Kríz J Cesk Pediatr; 1988 Nov; 43(11):667-70. PubMed ID: 3208342 [No Abstract] [Full Text] [Related]
38. Pharmacologic treatment of lower urinary tract dysfunction in the female patient. Wein AJ Urol Clin North Am; 1985 May; 12(2):259-69. PubMed ID: 2859679 [TBL] [Abstract][Full Text] [Related]